faeriewoods personal page - To The Moon

faeriewoods

faeriewoods

A foray into the money woods

35Follow

5Followers

0Topic

0Badge

2021-04-16

$CapLand IntCom T(C38U.SI)$will this go up in the short term?

2021-04-19

Please like thanks

Singapore-based TE Asia Healthcare looks to join US$1 billion club

2021-04-13

Nice

S&P 500 closes flat near record high in another muted session ahead of key inflation data

2021-04-10

So Sony still can buy?

Netflix Grabs Sony's Pay-TV Movie Deal From Starz

2022-04-20

KeppeL DC reit!

2021-04-21

Dropping

2021-04-22

Wow

Disney, Sony streaming deal may finally bring 'Spider-Man' to Disney+

2021-04-10

Nice

EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source

2021-04-18

Netflix or Amazon?

$544 Billion In Options Expire Today: Here's What Will Move

2021-04-11

Cool

Sorry, the original content has been removed

2021-04-16

Thanks

4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla

2021-04-15

What’s a good price to buy again?

2021-04-14

My pick of the REITS in Sg

2021-04-12

?

@Sufiknight:$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks poised to retest $5.50 in the near term.

2021-04-10

Apple at $133 still can buy?

2021-04-10

At this price still can buy?

2021-04-09

My first REIT

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578184198505037","uuid":"3578184198505037","gmtCreate":1615090606005,"gmtModify":1615992067156,"name":"faeriewoods","pinyin":"faeriewoods","introduction":"","introductionEn":"","signature":"A foray into the money woods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":35,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.02","exceedPercentage":"80.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9086113377,"gmtCreate":1650420860192,"gmtModify":1676534720644,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"KeppeL DC reit!&nbsp;","listText":"KeppeL DC reit!&nbsp;","text":"KeppeL DC reit!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086113377","isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":378402591,"gmtCreate":1619053648413,"gmtModify":1704718860789,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/378402591","repostId":"2129805442","repostType":2,"repost":{"id":"2129805442","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1619045100,"share":"https://ttm.financial/m/news/2129805442?lang=&edition=fundamental","pubTime":"2021-04-22 06:45","market":"us","language":"en","title":"Disney, Sony streaming deal may finally bring 'Spider-Man' to Disney+","url":"https://stock-news.laohu8.com/highlight/detail?id=2129805442","media":"Dow Jones","summary":"Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.Walt Disney Co. $$ and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. $$, starting in 2022 and running through 2026. Financial terms were not disclosed.The deal also grants Disney","content":"<blockquote>\n Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n</blockquote>\n<p>\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.</p>\n<p>Walt Disney Co. <a href=\"https://laohu8.com/S/DIS\">$(DIS)$</a> and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a>, starting in 2022 and running through 2026. Financial terms were not disclosed.</p>\n<p>The deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.</p>\n<p>While it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.</p>\n<p>Other popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"</p>\n<p>\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.</p>\n<p>Earlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.</p>\n<p>Disney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney, Sony streaming deal may finally bring 'Spider-Man' to Disney+</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney, Sony streaming deal may finally bring 'Spider-Man' to Disney+\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-04-22 06:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n</blockquote>\n<p>\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.</p>\n<p>Walt Disney Co. <a href=\"https://laohu8.com/S/DIS\">$(DIS)$</a> and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a>, starting in 2022 and running through 2026. Financial terms were not disclosed.</p>\n<p>The deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.</p>\n<p>While it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.</p>\n<p>Other popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"</p>\n<p>\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.</p>\n<p>Earlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.</p>\n<p>Disney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","03160":"华夏日股对冲"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129805442","content_text":"Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n\n\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.\nWalt Disney Co. $(DIS)$ and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. $(NFLX)$, starting in 2022 and running through 2026. Financial terms were not disclosed.\nThe deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.\nWhile it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.\nOther popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"\n\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.\nEarlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.\nDisney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":378850042,"gmtCreate":1619017044786,"gmtModify":1704718409300,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Dropping&nbsp;","listText":"Dropping&nbsp;","text":"Dropping","images":[{"img":"https://static.tigerbbs.com/fd9235408cd08ef2f2e22e96a29c99d0","width":"750","height":"1879"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/378850042","isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":379477681,"gmtCreate":1618792448943,"gmtModify":1704714877005,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Please like thanks&nbsp;","listText":"Please like thanks&nbsp;","text":"Please like thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/379477681","repostId":"2128863731","repostType":4,"repost":{"id":"2128863731","pubTimestamp":1618789491,"share":"https://ttm.financial/m/news/2128863731?lang=&edition=fundamental","pubTime":"2021-04-19 07:44","market":"sg","language":"en","title":"Singapore-based TE Asia Healthcare looks to join US$1 billion club","url":"https://stock-news.laohu8.com/highlight/detail?id=2128863731","media":"The Straits Times","summary":"SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expe","content":"<div>\n<p>SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore-based TE Asia Healthcare looks to join US$1 billion club</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore-based TE Asia Healthcare looks to join US$1 billion club\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HCSG":"医疗保健服务","HR":"医疗保健房地产信托","00662":"亚洲金融"},"source_url":"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128863731","content_text":"SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-east Asia, according to its chief executive officer.\n\n\nThe Singapore-based company plans to invest US$90 million mainly in Malaysia and Indonesia this year, building new cardiac hospitals and repurposing an existing medical facility in Kuala Lumpur into an orthopedic center, Mr Eng Aik Meng said in an interview. That would take TE Asia's total investment to US$260 million by the end of this year, he added.\nThe healthcare firm plans to double that investment in the next three to five years as it seeks to set foot in more countries and offers a broader range of specialized medical services, Mr Eng said.\n\n\n\n\n\n\n\"If we continue at this pace, this is easily a US$1 billion company\" in five years, he said.\nDemand for healthcare services, especially in specialized fields, is set to rise as countries in South-east Asia become more affluent. The average health-care spending in the region was at 4 per cent of gross domestic product in 2018, compared to 5.4 per cent in China and about 10 per cent globally, according to a report by the World Bank.\nTE Asia, which has annual revenue of more than US$150 million, focuses on oncology, cardiology and orthopedics. It will raise funds for its future investment from external investors when needed, Mr Eng said, adding that he doesn't rule out the possibility of a listing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":379878744,"gmtCreate":1618720955288,"gmtModify":1704714327667,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Netflix or Amazon?","listText":"Netflix or Amazon?","text":"Netflix or Amazon?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/379878744","repostId":"1175692875","repostType":4,"repost":{"id":"1175692875","pubTimestamp":1618582708,"share":"https://ttm.financial/m/news/1175692875?lang=&edition=fundamental","pubTime":"2021-04-16 22:18","market":"us","language":"en","title":"$544 Billion In Options Expire Today: Here's What Will Move","url":"https://stock-news.laohu8.com/highlight/detail?id=1175692875","media":"zerohedge","summary":"While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire","content":"<p>While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying prices. It's why, even though we are enjoying a beautiful spring week, Goldman notes that single stock options trading activity is elevated relative to historical levels. To wit, daily options volumes are up 70% in April, up from YTD lows of $2.4bn on 30-Mar.</p><p><b>In total, across single stocks, $544BN of options are set to expiry today, including $305BN calls.</b>As such, today’s expiry could be important for stocks with large open interest in at-the-money(ATM) options, as market makers delta-hedging their unusually large options portfolios will be active. This flow is likely to dampen volatility in some names while exacerbating stock price moves in others.</p><p>How to trade this?</p><p>As Goldman's Vishal Vivek writes, at major expirations, options traders track situations where<b>a large amount of open interest is set to expire.</b>In situations where there is a significant amount of expiring open interest in at-the-money strikes (strike prices at or very near the current stockprice), delta-hedging activity can impact the underlying stock’s trading that day. If market makers or other options traders who delta-hedge their positions are net long ATM options, expiration-related flow could have the effect of dampening stock price movements, causing the stock price to settle near the strike with large open interest. This situation is often referred to as a “pin” and can be an ideal situation fora large investor trying to enter/exit a stock position. Alternatively, if delta-hedgers are net short ATM options (have a “negative gamma” position), their hedging activity could exacerbate stock price moves.</p><p>What that means it expiration-related trades may cause trading activity to aggressively pick up for stocks with a significant amount of ATM open interest.</p><p>So to help traders looking to hop on for daytrading opportunities, here is a table identifying possible focus stocks with large ATM open interest expiring today, which is compared to the average daily volume of the underlying stocks. As Goldman puts it, \"<i>expiration-related activity is likely to have more of an impact if the open interest represents a significant percentage of the stock’s volume.\"</i></p><p><img src=\"https://static.tigerbbs.com/0dac61cb87c2f2700d8a0e8e64324f81\" tg-width=\"500\" tg-height=\"638\" referrerpolicy=\"no-referrer\">Finally, for what it's worth, this morning our friends at SpotGamma write that this has been a rather strange OPEX cycle, \"with a consistent almost mechanical bid pushing markets higher. We’ve not seen the Call Wall “breached” this many times before, but there are other aberrations that we’ve mentioned in previous notes – like net put sales. We’ve got some theories on this we are posting in a longer form piece.\"</p><p>According to SG, because implied volatility has now compressed (ie VIX at new lows) there is now more potential for “long term” volatility. Recall how as of late any sharp, violent drop in markets was bought so quickly (see chart below).<b>These bursts lower coincided with record VIX spikes, but a reflective snap-back bid would bring a market recovery of equal force as the VIX&nbsp; (i.e. implied volatility) reversed.</b></p><p><img src=\"https://static.tigerbbs.com/ae7a60d873792b825bdda669cafa0ed3\" tg-width=\"500\" tg-height=\"297\" referrerpolicy=\"no-referrer\">And one other curious observation from SpotGamma:</p><blockquote>When implied volatility is very high, its very sensitive to market moves and also signaling that markets are expecting more large moves ahead. As soon as markets would pause or catch a support level, that implied volatility would quickly reverse lower. <b>We often think of this analogy that if a shark stops swimming, it sinks ( partially true!). If the market stops dropping then Implied volatility sinks.</b></blockquote><p>With this, as we often talk about, lower implied volatility (ie lower VIX) signals market makers have to buy back short hedges which fuels rallies. SG's conclusion: this current level of lower implied volatility now gives the market more downside firepower.&nbsp; Starting with a lower implied volatility “slows down” that responsive “snap-back” buying mechanism.&nbsp; Additionally, gamma is higher when IV is lower so gamma flips may have more juice.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$544 Billion In Options Expire Today: Here's What Will Move</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$544 Billion In Options Expire Today: Here's What Will Move\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 22:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175692875","content_text":"While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying prices. It's why, even though we are enjoying a beautiful spring week, Goldman notes that single stock options trading activity is elevated relative to historical levels. To wit, daily options volumes are up 70% in April, up from YTD lows of $2.4bn on 30-Mar.In total, across single stocks, $544BN of options are set to expiry today, including $305BN calls.As such, today’s expiry could be important for stocks with large open interest in at-the-money(ATM) options, as market makers delta-hedging their unusually large options portfolios will be active. This flow is likely to dampen volatility in some names while exacerbating stock price moves in others.How to trade this?As Goldman's Vishal Vivek writes, at major expirations, options traders track situations wherea large amount of open interest is set to expire.In situations where there is a significant amount of expiring open interest in at-the-money strikes (strike prices at or very near the current stockprice), delta-hedging activity can impact the underlying stock’s trading that day. If market makers or other options traders who delta-hedge their positions are net long ATM options, expiration-related flow could have the effect of dampening stock price movements, causing the stock price to settle near the strike with large open interest. This situation is often referred to as a “pin” and can be an ideal situation fora large investor trying to enter/exit a stock position. Alternatively, if delta-hedgers are net short ATM options (have a “negative gamma” position), their hedging activity could exacerbate stock price moves.What that means it expiration-related trades may cause trading activity to aggressively pick up for stocks with a significant amount of ATM open interest.So to help traders looking to hop on for daytrading opportunities, here is a table identifying possible focus stocks with large ATM open interest expiring today, which is compared to the average daily volume of the underlying stocks. As Goldman puts it, \"expiration-related activity is likely to have more of an impact if the open interest represents a significant percentage of the stock’s volume.\"Finally, for what it's worth, this morning our friends at SpotGamma write that this has been a rather strange OPEX cycle, \"with a consistent almost mechanical bid pushing markets higher. We’ve not seen the Call Wall “breached” this many times before, but there are other aberrations that we’ve mentioned in previous notes – like net put sales. We’ve got some theories on this we are posting in a longer form piece.\"According to SG, because implied volatility has now compressed (ie VIX at new lows) there is now more potential for “long term” volatility. Recall how as of late any sharp, violent drop in markets was bought so quickly (see chart below).These bursts lower coincided with record VIX spikes, but a reflective snap-back bid would bring a market recovery of equal force as the VIX  (i.e. implied volatility) reversed.And one other curious observation from SpotGamma:When implied volatility is very high, its very sensitive to market moves and also signaling that markets are expecting more large moves ahead. As soon as markets would pause or catch a support level, that implied volatility would quickly reverse lower. We often think of this analogy that if a shark stops swimming, it sinks ( partially true!). If the market stops dropping then Implied volatility sinks.With this, as we often talk about, lower implied volatility (ie lower VIX) signals market makers have to buy back short hedges which fuels rallies. SG's conclusion: this current level of lower implied volatility now gives the market more downside firepower.  Starting with a lower implied volatility “slows down” that responsive “snap-back” buying mechanism.  Additionally, gamma is higher when IV is lower so gamma flips may have more juice.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370874899,"gmtCreate":1618578081311,"gmtModify":1704712979923,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>will this go up in the short term?","listText":"<a href=\"https://laohu8.com/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>will this go up in the short term?","text":"$CapLand IntCom T(C38U.SI)$will this go up in the short term?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/370874899","isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571394252154104","authorId":"3571394252154104","name":"JeffreyTan","avatar":"https://static.tigerbbs.com/8d285f70745313b30ab54f8d1af6baab","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3571394252154104","idStr":"3571394252154104"},"content":"more than a year.. sg stock grow too slow but they are stable in price","text":"more than a year.. sg stock grow too slow but they are stable in price","html":"more than a year.. sg stock grow too slow but they are stable in price"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370872712,"gmtCreate":1618577924936,"gmtModify":1704712977819,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/370872712","repostId":"2127664834","repostType":4,"repost":{"id":"2127664834","pubTimestamp":1618573860,"share":"https://ttm.financial/m/news/2127664834?lang=&edition=fundamental","pubTime":"2021-04-16 19:51","market":"us","language":"en","title":"4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2127664834","media":"Motley Fool","summary":"And they all have one key thing in common.","content":"<p>Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of <b>Tesla</b> (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b>. But Wood also likes several healthcare stocks. In this <i>Motley Fool Live</i> video <b>recorded on April 7</b>, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.</p>\n<p><b>Keith Speights:</b> All right. Let's switch to a fun story, Brian. Now, you and I, we cover healthcare. We don't get to talk about stocks like Tesla very often, we just don't. We're going to talk about Tesla, kind of.</p>\n<p>Cathie Wood, famous investor, very well-known investor, highly followed investor. Her ARK Invest came out not long ago with a 2025 price target for Tesla that caused all kinds of controversy. It's way higher than Tesla's current price. They took a beating for predicting that Tesla's shares were going to really just skyrocket over the next few years.</p>\n<p>But Cathie Wood also likes quite a few healthcare stocks. I'm curious, Brian. Are there any of Cathie Wood's favorite healthcare stocks that you think could deliver bigger gains than Tesla will over the next five years?</p>\n<p><b>Brian Orelli:</b> Yeah. The only <a href=\"https://laohu8.com/S/AONE\">one</a> in the top holdings that I saw that I own is <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX). It's big and in cystic fibrosis. Growth has been slowing down as it will treat more patients with its different medications. It's up to maybe three to four medications depending on how you count the combinations.</p>\n<p>It needs to find its next growth driver. There's plenty of pipeline candidates both internally developed, as well as licensed products. Among the licensed products, <b>CRISPR Therapeutics</b> (NASDAQ:CRSP) has a deal with the company. They have a treatment for beta-thalassemia and sickle cell that's already in clinical trials and has shown early efficacy, and then they have some earlier programs in Duchenne's muscular dystrophy, a disease called DM1, and cystic fibrosis.</p>\n<p>On the rest of her list, I really like <b>Regeneron</b> (NASDAQ:REGN). It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> that I've always wished I owned, but it always seemed a little expensive. But that's the way good companies go sometimes and so sometimes, you just have to bite the bullet and buy it and I never did.</p>\n<p>If you're going to buy a large biotech company, you want to go for one with a lot of shots on goal and Regeneron has maybe almost the most shots on goal. It's really done well. I can't even think of Regeneron drug that has actually failed. I think maybe that's one of the reasons why it's doing well, even though it's had a really high price. Valuation is just because it's had so few failures, it's done really well at developing antibodies and being successful at that.</p>\n<p><b>Anything on the list that you saw?</b></p>\n<p><b>Speights:</b> Yeah. First, I would agree with you on both Vertex and Regeneron. The tickers there by the way are VRTX for Vertex and REGN for Regeneron. Yeah. When you're looking at big biotechs, those two are my favorites.</p>\n<p>Like you Brian, I own Vertex. I don't own Regeneron, but also like you, I wish I had bought it several years ago. Those are great picks that I do think both of those depending on how their pipeline candidates play out over the next few years, both of those stocks could potentially beat Tesla.</p>\n<p>I also like and own <b>Teladoc Health</b> (NYSE:TDOC). Ticker there is TDOC. That's another Cathie Wood favorite that she is very bullish on. I think Teladoc Health has been beaten down quite a bit over the last couple of months, but I think it's a stock that could very easily outperform Tesla over the next five years as virtual care really gains momentum.</p>\n<p>I will throw in a much riskier stock that I don't own, but just I've started doing a little research into. It's a stock called <b>Twist Bioscience</b> (NASDAQ:TWST). The ticker there is TWST. What Twist does is it makes synthetic DNA. The company offers next-generation sequencing products. It develops antibodies for biopharma companies, it's working on storing data and DNA.</p>\n<p>The market cap right now is only around $6 billion. They generated revenue of $90 million last year. It's priced at a premium, but investors are expecting great things from Twist Bioscience. Again, it's one of Cathie Wood's favorite biotech stocks and it's one that, like I said, is really risky, but it could pay off over the long run. It's one that I'm keeping my eye on.</p>\n<p><b>Orelli:</b> Twist just came on to my watchlist like in the last week.</p>\n<p><b>Speights:</b> Yeah.</p>\n<p><b>Orelli:</b> Because it was spurred on by this podcast. Luke Timmerman does a podcast called <i>The Long Run</i>, and the CEO, Emily Leproust was on the podcast. I'll put that link to that podcast in the chat. If anybody wants to get more information on Twist and what they're doing, I think that was a really interesting podcast.</p>\n<p><b>Speights:</b> Maybe sometime in the not-too-distant future, Brian, you and I can go a little deeper, dive into Twist Bioscience just to give our viewers more information about this biotech that's on both of our watchlists right now.</p>\n<p><b>Orelli:</b> Yeah, that sounds good.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 19:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, ARK Innovation ETF. But Wood...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2127664834","content_text":"Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, ARK Innovation ETF. But Wood also likes several healthcare stocks. In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.\nKeith Speights: All right. Let's switch to a fun story, Brian. Now, you and I, we cover healthcare. We don't get to talk about stocks like Tesla very often, we just don't. We're going to talk about Tesla, kind of.\nCathie Wood, famous investor, very well-known investor, highly followed investor. Her ARK Invest came out not long ago with a 2025 price target for Tesla that caused all kinds of controversy. It's way higher than Tesla's current price. They took a beating for predicting that Tesla's shares were going to really just skyrocket over the next few years.\nBut Cathie Wood also likes quite a few healthcare stocks. I'm curious, Brian. Are there any of Cathie Wood's favorite healthcare stocks that you think could deliver bigger gains than Tesla will over the next five years?\nBrian Orelli: Yeah. The only one in the top holdings that I saw that I own is Vertex Pharmaceuticals (NASDAQ:VRTX). It's big and in cystic fibrosis. Growth has been slowing down as it will treat more patients with its different medications. It's up to maybe three to four medications depending on how you count the combinations.\nIt needs to find its next growth driver. There's plenty of pipeline candidates both internally developed, as well as licensed products. Among the licensed products, CRISPR Therapeutics (NASDAQ:CRSP) has a deal with the company. They have a treatment for beta-thalassemia and sickle cell that's already in clinical trials and has shown early efficacy, and then they have some earlier programs in Duchenne's muscular dystrophy, a disease called DM1, and cystic fibrosis.\nOn the rest of her list, I really like Regeneron (NASDAQ:REGN). It's one that I've always wished I owned, but it always seemed a little expensive. But that's the way good companies go sometimes and so sometimes, you just have to bite the bullet and buy it and I never did.\nIf you're going to buy a large biotech company, you want to go for one with a lot of shots on goal and Regeneron has maybe almost the most shots on goal. It's really done well. I can't even think of Regeneron drug that has actually failed. I think maybe that's one of the reasons why it's doing well, even though it's had a really high price. Valuation is just because it's had so few failures, it's done really well at developing antibodies and being successful at that.\nAnything on the list that you saw?\nSpeights: Yeah. First, I would agree with you on both Vertex and Regeneron. The tickers there by the way are VRTX for Vertex and REGN for Regeneron. Yeah. When you're looking at big biotechs, those two are my favorites.\nLike you Brian, I own Vertex. I don't own Regeneron, but also like you, I wish I had bought it several years ago. Those are great picks that I do think both of those depending on how their pipeline candidates play out over the next few years, both of those stocks could potentially beat Tesla.\nI also like and own Teladoc Health (NYSE:TDOC). Ticker there is TDOC. That's another Cathie Wood favorite that she is very bullish on. I think Teladoc Health has been beaten down quite a bit over the last couple of months, but I think it's a stock that could very easily outperform Tesla over the next five years as virtual care really gains momentum.\nI will throw in a much riskier stock that I don't own, but just I've started doing a little research into. It's a stock called Twist Bioscience (NASDAQ:TWST). The ticker there is TWST. What Twist does is it makes synthetic DNA. The company offers next-generation sequencing products. It develops antibodies for biopharma companies, it's working on storing data and DNA.\nThe market cap right now is only around $6 billion. They generated revenue of $90 million last year. It's priced at a premium, but investors are expecting great things from Twist Bioscience. Again, it's one of Cathie Wood's favorite biotech stocks and it's one that, like I said, is really risky, but it could pay off over the long run. It's one that I'm keeping my eye on.\nOrelli: Twist just came on to my watchlist like in the last week.\nSpeights: Yeah.\nOrelli: Because it was spurred on by this podcast. Luke Timmerman does a podcast called The Long Run, and the CEO, Emily Leproust was on the podcast. I'll put that link to that podcast in the chat. If anybody wants to get more information on Twist and what they're doing, I think that was a really interesting podcast.\nSpeights: Maybe sometime in the not-too-distant future, Brian, you and I can go a little deeper, dive into Twist Bioscience just to give our viewers more information about this biotech that's on both of our watchlists right now.\nOrelli: Yeah, that sounds good.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347016604,"gmtCreate":1618449105508,"gmtModify":1704710968776,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"What’s&nbsp;a good price&nbsp;to buy again?","listText":"What’s&nbsp;a good price&nbsp;to buy again?","text":"What’s a good price to buy again?","images":[{"img":"https://static.tigerbbs.com/6b80b90c166da6181d19ef5090442fc7","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/347016604","isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":344885164,"gmtCreate":1618397176258,"gmtModify":1704710162727,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"My pick of the REITS in Sg&nbsp;","listText":"My pick of the REITS in Sg&nbsp;","text":"My pick of the REITS in Sg","images":[{"img":"https://static.tigerbbs.com/a3cf30b8a1bd1d8884e810aea28e9223","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344885164","isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":345165717,"gmtCreate":1618289119739,"gmtModify":1704708654046,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345165717","repostId":"1146450605","repostType":4,"repost":{"id":"1146450605","pubTimestamp":1618271053,"share":"https://ttm.financial/m/news/1146450605?lang=&edition=fundamental","pubTime":"2021-04-13 07:44","market":"us","language":"en","title":"S&P 500 closes flat near record high in another muted session ahead of key inflation data","url":"https://stock-news.laohu8.com/highlight/detail?id=1146450605","media":"CNBC","summary":"U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of","content":"<div>\n<p>U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 closes flat near record high in another muted session ahead of key inflation data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 closes flat near record high in another muted session ahead of key inflation data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","INTC":"英特尔","NVDA":"英伟达","NUAN":"微妙通讯",".DJI":"道琼斯","MSFT":"微软","TSLA":"特斯拉"},"source_url":"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1146450605","content_text":"U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped less than 1 point to 4,127.99 after closing at a record high in the previous session. The Dow Jones Industrial Average slipped 55.20 points, or 0.2%, to 33,745.40, also falling from a record high. Intel was the biggest decliner in the blue-chip Dow, dropping more than 4%. The Nasdaq Composite fell 0.4% to 13,850.00.Wall Street has been relatively quiet with the S&P 500 moving within 1% for five sessions in a row. Market volatility has declined to pre-pandemic levels amid rising reopening optimism. The Cboe Volatility Index, AKA the VIX or the market’s fear gauge, has traded below 18 for the past four days, a level unseen since February 2020.Shares of Nuance Communications jumped nearly 16% after Microsoft announced it will buy the speech recognition company in a $16 billion deal.The Nuance acquisition represents Microsoft’s largest acquisition since it bought LinkedIn for more than $26 billion in 2016.Nvidia jumped 5.6% after the chip giant said it first quarter revenue for fiscal 2022 is tracking above its previously provided outlook and that it expects demand to continue to exceed supply for much of this year.Nvidia plans new chip to compete with intel in data-center market.The weakness in reopening plays weighed on the overall market with shares of Carnival and Norwegian Cruise Line off more than 4% each. United Airlines fell 3.9% after the carrier said its first-quarter revenue is expected to fall 66% compared with the same period in 2019. The new guidance fell near the top of the range between 65% and 70% that the company had previously forecast.“Amid new highs it’s not surprising for the market to be moving somewhat in a holding pattern of late,” said Chris Larkin,managing director of trading and investing product at E-Trade. “All eyes will likely be on the CPI read tomorrow for a benchmark on where we stand on the inflation front. And of course we’re ushering in earnings season which could be a catalyst for market moves over the next few weeks.”The first-quarter earnings reporting season begins this week, with expectations set for broadly positive news and an uptrend for U.S. equities thanks to a recovering economy. Many of the nation’s largest banks, including Goldman Sachs and JPMorgan Chase will this week report results for the three months ended March 31.This week is also packed with Federal Reserve speeches and key economic data including a hotly anticipated inflation readingTuesday, when the U.S. consumer price index is released. Economists polled by Dow Jones anticipate a 0.5% gain in CPI month over month and a 2.5% increase from last year’s level.Tesla gained 3.7% to above $700 Monday after Canaccord Genuity upgraded the stock to buy and raised its price target to $1,071, citing its battery innovations.Fed Chairman Jerome Powell on Sunday reiterated that the Fed wants to see inflation rise above its 2% for an extended period before officials move to raise interest rates.“We want to see inflation move up to 2% — and we mean that on a sustainable basis, we don’t mean just tap the base once,” Powell said in an interview that aired Sunday evening on CBS News’ “60 Minutes.” “But then we’d also like to see it on track to move moderately above 2% for some time.”He added that amid an accelerated Covid-19 vaccine rollout and strong fiscal support, the U.S. economy appears to be at a turning point.Powell will also speak Wednesday at an Economic Club of Washington event.Investors will also keep an eye on President Joe Biden’s effort to advance a major infrastructure proposal known as the American Jobs Plan. Biden, who with other Democrats promised significant an infrastructure overhaul in the 2020 elections, wil lmeet with a bipartisan group of lawmakers on Monday to try to persuade Capitol Hill to back the $2 trillion package.Congress will return to Washington this week and be in session for the first time since Biden debuted his proposal, which earmarks hundreds of billions of dollars for roads, bridges, airports, broadband, electric vehicles, housing and job training.The president’s plan would also increase the corporate tax rate to 28% and crack down on other overseas tax avoidance strategies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342612428,"gmtCreate":1618209305264,"gmtModify":1704707532364,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342612428","repostId":"342890542","repostType":1,"repost":{"id":342890542,"gmtCreate":1618195126286,"gmtModify":1704707355770,"author":{"id":"3553398469738690","authorId":"3553398469738690","name":"Sufiknight","avatar":"https://static.tigerbbs.com/15e40690d5aba75f7d0bfb1c31e35254","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553398469738690","idStr":"3553398469738690"},"themes":[],"htmlText":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks&nbsp;poised to retest $5.50 in the near term.&nbsp;","listText":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks&nbsp;poised to retest $5.50 in the near term.&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks poised to retest $5.50 in the near term.","images":[{"img":"https://static.tigerbbs.com/4eb4bdaa097a9d13f0bafabb978b7745","width":"720","height":"1549"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342890542","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342023876,"gmtCreate":1618132449795,"gmtModify":1704706884610,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342023876","repostId":"1104081344","repostType":4,"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346830932,"gmtCreate":1618019441126,"gmtModify":1704706011872,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346830932","repostId":"2126038125","repostType":4,"repost":{"id":"2126038125","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617981432,"share":"https://ttm.financial/m/news/2126038125?lang=&edition=fundamental","pubTime":"2021-04-09 23:17","market":"us","language":"en","title":"EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source","url":"https://stock-news.laohu8.com/highlight/detail?id=2126038125","media":"Reuters","summary":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch ","content":"<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-09 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126038125","content_text":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.\nEarlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.\nThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.\nA Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.\nHe also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.\n“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.\nThe two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.\nPfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.\nThe vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346896245,"gmtCreate":1618019202687,"gmtModify":1704706006194,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"So Sony still can buy?","listText":"So Sony still can buy?","text":"So Sony still can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346896245","repostId":"2126315033","repostType":4,"repost":{"id":"2126315033","pubTimestamp":1617981660,"share":"https://ttm.financial/m/news/2126315033?lang=&edition=fundamental","pubTime":"2021-04-09 23:21","market":"us","language":"en","title":"Netflix Grabs Sony's Pay-TV Movie Deal From Starz","url":"https://stock-news.laohu8.com/highlight/detail?id=2126315033","media":"Anders Bylund","summary":"Most Hollywood studios have started their own streaming services to compete in the evolving media market. Sony picked a well-established partner instead.","content":"<p>Video-streaming veteran <b>Netflix</b> (NASDAQ:NFLX) just signed a multiyear content deal with <b>Sony</b> (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution window from longtime partner <a href=\"https://laohu8.com/S/STRZA\">Starz</a> to Netflix, putting the studio's theatrical releases on Netflix's global streaming platform.</p><p>Sony and Netflix already had a streaming agreement for animated content, but this deal expands that partnership to all genres and production types. Titles making their home entertainment premiere in 2022 on Netflix rather than <b>Lions Gate Entertainment</b> (NYSE:LGF-A) (NYSE:LGF-B) subsidiary <a href=\"https://laohu8.com/S/STRZB\">Starz</a> will include the Brad Pitt thriller <i>Bullet Train</i>, the ensemble-cast action movie <i>Uncharted</i>, and the Reese Witherspoon-produced murder drama <i>Where the Crawdads Sing</i>.</p><p><img src=\"https://static.tigerbbs.com/9243727dc46ddf4fb557f7d44eef1325\" tg-width=\"700\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>Netflix will also distribute future titles in Sony's established film franchises such as <i>Venom</i>, <i>Jumanji</i>, and <i>Bad Boys</i>, as well as any other new projects that Sony's several studio brands may come up with. The deal also allows licensing rights for Netflix to show some titles from Sony's enormous back catalog.</p><p>Furthermore, Netflix gets \"first look\" privilege to consider developing any direct-to-streaming titles Sony's studios may develop during this agreement.&nbsp;Netflix has committed to releasing an undisclosed minimum number of such productions, which will add exclusive Sony/Netflix content on top of Sony's continuing theatrical productions.</p><p>The terms of the deal were not disclosed, but Netflix's payments to Sony should be \"record setting\" for a pay-TV distribution window, according to <i>Variety</i>'s anonymous insider sources.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Grabs Sony's Pay-TV Movie Deal From Starz</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Grabs Sony's Pay-TV Movie Deal From Starz\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/><strong>Anders Bylund</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Video-streaming veteran Netflix (NASDAQ:NFLX) just signed a multiyear content deal with Sony (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞","QNETCN":"纳斯达克中美互联网老虎指数"},"source_url":"https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126315033","content_text":"Video-streaming veteran Netflix (NASDAQ:NFLX) just signed a multiyear content deal with Sony (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution window from longtime partner Starz to Netflix, putting the studio's theatrical releases on Netflix's global streaming platform.Sony and Netflix already had a streaming agreement for animated content, but this deal expands that partnership to all genres and production types. Titles making their home entertainment premiere in 2022 on Netflix rather than Lions Gate Entertainment (NYSE:LGF-A) (NYSE:LGF-B) subsidiary Starz will include the Brad Pitt thriller Bullet Train, the ensemble-cast action movie Uncharted, and the Reese Witherspoon-produced murder drama Where the Crawdads Sing.Image source: Getty Images.Netflix will also distribute future titles in Sony's established film franchises such as Venom, Jumanji, and Bad Boys, as well as any other new projects that Sony's several studio brands may come up with. The deal also allows licensing rights for Netflix to show some titles from Sony's enormous back catalog.Furthermore, Netflix gets \"first look\" privilege to consider developing any direct-to-streaming titles Sony's studios may develop during this agreement. Netflix has committed to releasing an undisclosed minimum number of such productions, which will add exclusive Sony/Netflix content on top of Sony's continuing theatrical productions.The terms of the deal were not disclosed, but Netflix's payments to Sony should be \"record setting\" for a pay-TV distribution window, according to Variety's anonymous insider sources.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346898819,"gmtCreate":1618019140131,"gmtModify":1704706004418,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Apple at $133 still can buy?","listText":"Apple at $133 still can buy?","text":"Apple at $133 still can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346898819","isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346893343,"gmtCreate":1618019067682,"gmtModify":1704706000862,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"At this price still can buy?","listText":"At this price still can buy?","text":"At this price still can buy?","images":[{"img":"https://static.tigerbbs.com/e2ded09140977194799e5916bdaf20a5","width":"750","height":"2602"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346893343","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":348633124,"gmtCreate":1617924878168,"gmtModify":1704704794599,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"My first REIT","listText":"My first REIT","text":"My first REIT","images":[{"img":"https://static.tigerbbs.com/15ef6dbba2ea7c9c67f5d98d332c8bb4","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348633124","isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":370874899,"gmtCreate":1618578081311,"gmtModify":1704712979923,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>will this go up in the short term?","listText":"<a href=\"https://laohu8.com/S/C38U.SI\">$CapLand IntCom T(C38U.SI)$</a>will this go up in the short term?","text":"$CapLand IntCom T(C38U.SI)$will this go up in the short term?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/370874899","isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571394252154104","authorId":"3571394252154104","name":"JeffreyTan","avatar":"https://static.tigerbbs.com/8d285f70745313b30ab54f8d1af6baab","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3571394252154104","idStr":"3571394252154104"},"content":"more than a year.. sg stock grow too slow but they are stable in price","text":"more than a year.. sg stock grow too slow but they are stable in price","html":"more than a year.. sg stock grow too slow but they are stable in price"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":379477681,"gmtCreate":1618792448943,"gmtModify":1704714877005,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Please like thanks&nbsp;","listText":"Please like thanks&nbsp;","text":"Please like thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/379477681","repostId":"2128863731","repostType":4,"repost":{"id":"2128863731","pubTimestamp":1618789491,"share":"https://ttm.financial/m/news/2128863731?lang=&edition=fundamental","pubTime":"2021-04-19 07:44","market":"sg","language":"en","title":"Singapore-based TE Asia Healthcare looks to join US$1 billion club","url":"https://stock-news.laohu8.com/highlight/detail?id=2128863731","media":"The Straits Times","summary":"SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expe","content":"<div>\n<p>SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore-based TE Asia Healthcare looks to join US$1 billion club</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore-based TE Asia Healthcare looks to join US$1 billion club\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HCSG":"医疗保健服务","HR":"医疗保健房地产信托","00662":"亚洲金融"},"source_url":"http://www.straitstimes.com/business/companies-markets/singapore-based-te-asia-healthcare-looks-to-join-us1-billion-club","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128863731","content_text":"SINGAPORE (BLOOMBERG) - TE Asia Healthcare Partners, backed by private equity firm TPG Capital, expects to achieve a valuation of US$1 billion (S$1.33 billion) in five years as it expands in South-east Asia, according to its chief executive officer.\n\n\nThe Singapore-based company plans to invest US$90 million mainly in Malaysia and Indonesia this year, building new cardiac hospitals and repurposing an existing medical facility in Kuala Lumpur into an orthopedic center, Mr Eng Aik Meng said in an interview. That would take TE Asia's total investment to US$260 million by the end of this year, he added.\nThe healthcare firm plans to double that investment in the next three to five years as it seeks to set foot in more countries and offers a broader range of specialized medical services, Mr Eng said.\n\n\n\n\n\n\n\"If we continue at this pace, this is easily a US$1 billion company\" in five years, he said.\nDemand for healthcare services, especially in specialized fields, is set to rise as countries in South-east Asia become more affluent. The average health-care spending in the region was at 4 per cent of gross domestic product in 2018, compared to 5.4 per cent in China and about 10 per cent globally, according to a report by the World Bank.\nTE Asia, which has annual revenue of more than US$150 million, focuses on oncology, cardiology and orthopedics. It will raise funds for its future investment from external investors when needed, Mr Eng said, adding that he doesn't rule out the possibility of a listing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345165717,"gmtCreate":1618289119739,"gmtModify":1704708654046,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345165717","repostId":"1146450605","repostType":4,"repost":{"id":"1146450605","pubTimestamp":1618271053,"share":"https://ttm.financial/m/news/1146450605?lang=&edition=fundamental","pubTime":"2021-04-13 07:44","market":"us","language":"en","title":"S&P 500 closes flat near record high in another muted session ahead of key inflation data","url":"https://stock-news.laohu8.com/highlight/detail?id=1146450605","media":"CNBC","summary":"U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of","content":"<div>\n<p>U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 closes flat near record high in another muted session ahead of key inflation data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 closes flat near record high in another muted session ahead of key inflation data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-13 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped ...</p>\n\n<a href=\"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","INTC":"英特尔","NVDA":"英伟达","NUAN":"微妙通讯",".DJI":"道琼斯","MSFT":"微软","TSLA":"特斯拉"},"source_url":"https://www.cnbc.com/2021/04/11/stock-market-futures-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1146450605","content_text":"U.S. stocks hovered near their record levels on Monday as dull trading resumed before the release of widely-watched inflation data and the start of first-quarter corporate earnings.The S&P 500 dipped less than 1 point to 4,127.99 after closing at a record high in the previous session. The Dow Jones Industrial Average slipped 55.20 points, or 0.2%, to 33,745.40, also falling from a record high. Intel was the biggest decliner in the blue-chip Dow, dropping more than 4%. The Nasdaq Composite fell 0.4% to 13,850.00.Wall Street has been relatively quiet with the S&P 500 moving within 1% for five sessions in a row. Market volatility has declined to pre-pandemic levels amid rising reopening optimism. The Cboe Volatility Index, AKA the VIX or the market’s fear gauge, has traded below 18 for the past four days, a level unseen since February 2020.Shares of Nuance Communications jumped nearly 16% after Microsoft announced it will buy the speech recognition company in a $16 billion deal.The Nuance acquisition represents Microsoft’s largest acquisition since it bought LinkedIn for more than $26 billion in 2016.Nvidia jumped 5.6% after the chip giant said it first quarter revenue for fiscal 2022 is tracking above its previously provided outlook and that it expects demand to continue to exceed supply for much of this year.Nvidia plans new chip to compete with intel in data-center market.The weakness in reopening plays weighed on the overall market with shares of Carnival and Norwegian Cruise Line off more than 4% each. United Airlines fell 3.9% after the carrier said its first-quarter revenue is expected to fall 66% compared with the same period in 2019. The new guidance fell near the top of the range between 65% and 70% that the company had previously forecast.“Amid new highs it’s not surprising for the market to be moving somewhat in a holding pattern of late,” said Chris Larkin,managing director of trading and investing product at E-Trade. “All eyes will likely be on the CPI read tomorrow for a benchmark on where we stand on the inflation front. And of course we’re ushering in earnings season which could be a catalyst for market moves over the next few weeks.”The first-quarter earnings reporting season begins this week, with expectations set for broadly positive news and an uptrend for U.S. equities thanks to a recovering economy. Many of the nation’s largest banks, including Goldman Sachs and JPMorgan Chase will this week report results for the three months ended March 31.This week is also packed with Federal Reserve speeches and key economic data including a hotly anticipated inflation readingTuesday, when the U.S. consumer price index is released. Economists polled by Dow Jones anticipate a 0.5% gain in CPI month over month and a 2.5% increase from last year’s level.Tesla gained 3.7% to above $700 Monday after Canaccord Genuity upgraded the stock to buy and raised its price target to $1,071, citing its battery innovations.Fed Chairman Jerome Powell on Sunday reiterated that the Fed wants to see inflation rise above its 2% for an extended period before officials move to raise interest rates.“We want to see inflation move up to 2% — and we mean that on a sustainable basis, we don’t mean just tap the base once,” Powell said in an interview that aired Sunday evening on CBS News’ “60 Minutes.” “But then we’d also like to see it on track to move moderately above 2% for some time.”He added that amid an accelerated Covid-19 vaccine rollout and strong fiscal support, the U.S. economy appears to be at a turning point.Powell will also speak Wednesday at an Economic Club of Washington event.Investors will also keep an eye on President Joe Biden’s effort to advance a major infrastructure proposal known as the American Jobs Plan. Biden, who with other Democrats promised significant an infrastructure overhaul in the 2020 elections, wil lmeet with a bipartisan group of lawmakers on Monday to try to persuade Capitol Hill to back the $2 trillion package.Congress will return to Washington this week and be in session for the first time since Biden debuted his proposal, which earmarks hundreds of billions of dollars for roads, bridges, airports, broadband, electric vehicles, housing and job training.The president’s plan would also increase the corporate tax rate to 28% and crack down on other overseas tax avoidance strategies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346896245,"gmtCreate":1618019202687,"gmtModify":1704706006194,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"So Sony still can buy?","listText":"So Sony still can buy?","text":"So Sony still can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346896245","repostId":"2126315033","repostType":4,"repost":{"id":"2126315033","pubTimestamp":1617981660,"share":"https://ttm.financial/m/news/2126315033?lang=&edition=fundamental","pubTime":"2021-04-09 23:21","market":"us","language":"en","title":"Netflix Grabs Sony's Pay-TV Movie Deal From Starz","url":"https://stock-news.laohu8.com/highlight/detail?id=2126315033","media":"Anders Bylund","summary":"Most Hollywood studios have started their own streaming services to compete in the evolving media market. Sony picked a well-established partner instead.","content":"<p>Video-streaming veteran <b>Netflix</b> (NASDAQ:NFLX) just signed a multiyear content deal with <b>Sony</b> (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution window from longtime partner <a href=\"https://laohu8.com/S/STRZA\">Starz</a> to Netflix, putting the studio's theatrical releases on Netflix's global streaming platform.</p><p>Sony and Netflix already had a streaming agreement for animated content, but this deal expands that partnership to all genres and production types. Titles making their home entertainment premiere in 2022 on Netflix rather than <b>Lions Gate Entertainment</b> (NYSE:LGF-A) (NYSE:LGF-B) subsidiary <a href=\"https://laohu8.com/S/STRZB\">Starz</a> will include the Brad Pitt thriller <i>Bullet Train</i>, the ensemble-cast action movie <i>Uncharted</i>, and the Reese Witherspoon-produced murder drama <i>Where the Crawdads Sing</i>.</p><p><img src=\"https://static.tigerbbs.com/9243727dc46ddf4fb557f7d44eef1325\" tg-width=\"700\" tg-height=\"534\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>Netflix will also distribute future titles in Sony's established film franchises such as <i>Venom</i>, <i>Jumanji</i>, and <i>Bad Boys</i>, as well as any other new projects that Sony's several studio brands may come up with. The deal also allows licensing rights for Netflix to show some titles from Sony's enormous back catalog.</p><p>Furthermore, Netflix gets \"first look\" privilege to consider developing any direct-to-streaming titles Sony's studios may develop during this agreement.&nbsp;Netflix has committed to releasing an undisclosed minimum number of such productions, which will add exclusive Sony/Netflix content on top of Sony's continuing theatrical productions.</p><p>The terms of the deal were not disclosed, but Netflix's payments to Sony should be \"record setting\" for a pay-TV distribution window, according to <i>Variety</i>'s anonymous insider sources.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Grabs Sony's Pay-TV Movie Deal From Starz</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Grabs Sony's Pay-TV Movie Deal From Starz\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/><strong>Anders Bylund</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Video-streaming veteran Netflix (NASDAQ:NFLX) just signed a multiyear content deal with Sony (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞","QNETCN":"纳斯达克中美互联网老虎指数"},"source_url":"https://www.fool.com/investing/2021/04/09/netflix-grabs-sonys-pay-tv-movie-deal-from-starz/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126315033","content_text":"Video-streaming veteran Netflix (NASDAQ:NFLX) just signed a multiyear content deal with Sony (NYSE:SNE) Pictures Entertainment. Starting in 2022, Sony will move its exclusive pay-TV distribution window from longtime partner Starz to Netflix, putting the studio's theatrical releases on Netflix's global streaming platform.Sony and Netflix already had a streaming agreement for animated content, but this deal expands that partnership to all genres and production types. Titles making their home entertainment premiere in 2022 on Netflix rather than Lions Gate Entertainment (NYSE:LGF-A) (NYSE:LGF-B) subsidiary Starz will include the Brad Pitt thriller Bullet Train, the ensemble-cast action movie Uncharted, and the Reese Witherspoon-produced murder drama Where the Crawdads Sing.Image source: Getty Images.Netflix will also distribute future titles in Sony's established film franchises such as Venom, Jumanji, and Bad Boys, as well as any other new projects that Sony's several studio brands may come up with. The deal also allows licensing rights for Netflix to show some titles from Sony's enormous back catalog.Furthermore, Netflix gets \"first look\" privilege to consider developing any direct-to-streaming titles Sony's studios may develop during this agreement. Netflix has committed to releasing an undisclosed minimum number of such productions, which will add exclusive Sony/Netflix content on top of Sony's continuing theatrical productions.The terms of the deal were not disclosed, but Netflix's payments to Sony should be \"record setting\" for a pay-TV distribution window, according to Variety's anonymous insider sources.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9086113377,"gmtCreate":1650420860192,"gmtModify":1676534720644,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"KeppeL DC reit!&nbsp;","listText":"KeppeL DC reit!&nbsp;","text":"KeppeL DC reit!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086113377","isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":378850042,"gmtCreate":1619017044786,"gmtModify":1704718409300,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Dropping&nbsp;","listText":"Dropping&nbsp;","text":"Dropping","images":[{"img":"https://static.tigerbbs.com/fd9235408cd08ef2f2e22e96a29c99d0","width":"750","height":"1879"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/378850042","isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":378402591,"gmtCreate":1619053648413,"gmtModify":1704718860789,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/378402591","repostId":"2129805442","repostType":2,"repost":{"id":"2129805442","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1619045100,"share":"https://ttm.financial/m/news/2129805442?lang=&edition=fundamental","pubTime":"2021-04-22 06:45","market":"us","language":"en","title":"Disney, Sony streaming deal may finally bring 'Spider-Man' to Disney+","url":"https://stock-news.laohu8.com/highlight/detail?id=2129805442","media":"Dow Jones","summary":"Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.Walt Disney Co. $$ and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. $$, starting in 2022 and running through 2026. Financial terms were not disclosed.The deal also grants Disney","content":"<blockquote>\n Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n</blockquote>\n<p>\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.</p>\n<p>Walt Disney Co. <a href=\"https://laohu8.com/S/DIS\">$(DIS)$</a> and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a>, starting in 2022 and running through 2026. Financial terms were not disclosed.</p>\n<p>The deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.</p>\n<p>While it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.</p>\n<p>Other popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"</p>\n<p>\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.</p>\n<p>Earlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.</p>\n<p>Disney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney, Sony streaming deal may finally bring 'Spider-Man' to Disney+</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney, Sony streaming deal may finally bring 'Spider-Man' to Disney+\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-04-22 06:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n</blockquote>\n<p>\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.</p>\n<p>Walt Disney Co. <a href=\"https://laohu8.com/S/DIS\">$(DIS)$</a> and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a>, starting in 2022 and running through 2026. Financial terms were not disclosed.</p>\n<p>The deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.</p>\n<p>While it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.</p>\n<p>Other popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"</p>\n<p>\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.</p>\n<p>Earlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.</p>\n<p>Disney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","03160":"华夏日股对冲"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129805442","content_text":"Multi-year deal gives Disney access to Sony's library, and rights to new movies after they stream on Netflix.\n\n\"Spider-Man\" could soon join the Marvel Cinematic Universe -- at least in terms of where it streams.\nWalt Disney Co. $(DIS)$ and Sony Pictures announced a multi-year licensing deal Wednesday giving Disney streaming rights for upcoming Sony movies after their initial runs on Netflix Inc. $(NFLX)$, starting in 2022 and running through 2026. Financial terms were not disclosed.\nThe deal also grants Disney access to Sony's library of movies, including the popular \"Spider-Man\" series. While the character Spider-Man has appeared in Disney's \"Avengers\" movies, the \"Spider-Man\" franchise is a separate entity owned by Sony.\nWhile it is unclear exactly which Disney entities Spidey and other Sony movies will end up streaming on, Disney+ is home to the rest of the blockbuster Marvel-movie franchise. Disney-controlled Hulu will also get \"a significant number of library titles\" as soon as June, the companies said. Sony releases will also be seen on Disney's ABC, Disney Channels, Freeform, FX and National Geographic channels.\nOther popular Sony franchises include \"Jumanji\" and \"Hotel Transylvania,\" as well as Marvel movies such as \"Venom\" and the upcoming \"Morbius.\"\n\"This is a win for fans, who will benefit from the ability to access the very best content from two of Hollywood's most prolific studios across a multitude of viewing platforms and experiences,\" Disney executive Chuck Saftler, who helped negotiate the deal, said in a statement.\nEarlier this month, Sony and Netflix announced a deal giving the streaming giant first crack at streaming Sony's theatrical releases, for around 18-month windows. Under Wednesday's deal, Disney would get the streaming rights to new releases after Netflix's exclusive window ends.\nDisney shares are up 1% year to date, and up 81% over the past 12 months. American Depository Receipts of Sony Corp. (6758.TO) are up 7.3% this year, and up 73% over the past year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346830932,"gmtCreate":1618019441126,"gmtModify":1704706011872,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346830932","repostId":"2126038125","repostType":4,"repost":{"id":"2126038125","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617981432,"share":"https://ttm.financial/m/news/2126038125?lang=&edition=fundamental","pubTime":"2021-04-09 23:17","market":"us","language":"en","title":"EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source","url":"https://stock-news.laohu8.com/highlight/detail?id=2126038125","media":"Reuters","summary":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch ","content":"<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU seeks new contract with Pfizer/BioNTech for up to 1.8 billion vaccines from 2022 -EU source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-09 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.</p>\n<p>Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.</p>\n<p>The EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.</p>\n<p>A Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.</p>\n<p>He also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.</p>\n<p>“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.</p>\n<p>The two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.</p>\n<p>Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.</p>\n<p>The vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126038125","content_text":"BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments’ approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of their COVID-19 vaccines to be delivered in 2022 and 2023, an EU official told Reuters.\nEarlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.\nThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer-BioNTech and that EU governments backed the plan, though there was not yet a definitive approval.\nA Commission spokesman confirmed plans to buy the additional doses, of which half would be optional.\nHe also confirmed that the EU executive had already identified one supplier, a manufacturer of mRNA vaccines, but declined to comment on which company would be approached to negotiate the contract.\n“If provided the opportunity Pfizer and BioNTech are prepared to supply Europe with hundreds of millions of doses of COVID vaccines in 2022 and 2023 produced in our manufacturing facilities in Europe,” a Pfizer spokesman said.\nThe two companies have the capacity to produce more than 3 billion doses of vaccine in 2022, he added.\nPfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.\nThe vaccines would be delivered under monthly timetables and with clauses obliging the supplier to deliver, the EU official said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":379878744,"gmtCreate":1618720955288,"gmtModify":1704714327667,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Netflix or Amazon?","listText":"Netflix or Amazon?","text":"Netflix or Amazon?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/379878744","repostId":"1175692875","repostType":4,"repost":{"id":"1175692875","pubTimestamp":1618582708,"share":"https://ttm.financial/m/news/1175692875?lang=&edition=fundamental","pubTime":"2021-04-16 22:18","market":"us","language":"en","title":"$544 Billion In Options Expire Today: Here's What Will Move","url":"https://stock-news.laohu8.com/highlight/detail?id=1175692875","media":"zerohedge","summary":"While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire","content":"<p>While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying prices. It's why, even though we are enjoying a beautiful spring week, Goldman notes that single stock options trading activity is elevated relative to historical levels. To wit, daily options volumes are up 70% in April, up from YTD lows of $2.4bn on 30-Mar.</p><p><b>In total, across single stocks, $544BN of options are set to expiry today, including $305BN calls.</b>As such, today’s expiry could be important for stocks with large open interest in at-the-money(ATM) options, as market makers delta-hedging their unusually large options portfolios will be active. This flow is likely to dampen volatility in some names while exacerbating stock price moves in others.</p><p>How to trade this?</p><p>As Goldman's Vishal Vivek writes, at major expirations, options traders track situations where<b>a large amount of open interest is set to expire.</b>In situations where there is a significant amount of expiring open interest in at-the-money strikes (strike prices at or very near the current stockprice), delta-hedging activity can impact the underlying stock’s trading that day. If market makers or other options traders who delta-hedge their positions are net long ATM options, expiration-related flow could have the effect of dampening stock price movements, causing the stock price to settle near the strike with large open interest. This situation is often referred to as a “pin” and can be an ideal situation fora large investor trying to enter/exit a stock position. Alternatively, if delta-hedgers are net short ATM options (have a “negative gamma” position), their hedging activity could exacerbate stock price moves.</p><p>What that means it expiration-related trades may cause trading activity to aggressively pick up for stocks with a significant amount of ATM open interest.</p><p>So to help traders looking to hop on for daytrading opportunities, here is a table identifying possible focus stocks with large ATM open interest expiring today, which is compared to the average daily volume of the underlying stocks. As Goldman puts it, \"<i>expiration-related activity is likely to have more of an impact if the open interest represents a significant percentage of the stock’s volume.\"</i></p><p><img src=\"https://static.tigerbbs.com/0dac61cb87c2f2700d8a0e8e64324f81\" tg-width=\"500\" tg-height=\"638\" referrerpolicy=\"no-referrer\">Finally, for what it's worth, this morning our friends at SpotGamma write that this has been a rather strange OPEX cycle, \"with a consistent almost mechanical bid pushing markets higher. We’ve not seen the Call Wall “breached” this many times before, but there are other aberrations that we’ve mentioned in previous notes – like net put sales. We’ve got some theories on this we are posting in a longer form piece.\"</p><p>According to SG, because implied volatility has now compressed (ie VIX at new lows) there is now more potential for “long term” volatility. Recall how as of late any sharp, violent drop in markets was bought so quickly (see chart below).<b>These bursts lower coincided with record VIX spikes, but a reflective snap-back bid would bring a market recovery of equal force as the VIX&nbsp; (i.e. implied volatility) reversed.</b></p><p><img src=\"https://static.tigerbbs.com/ae7a60d873792b825bdda669cafa0ed3\" tg-width=\"500\" tg-height=\"297\" referrerpolicy=\"no-referrer\">And one other curious observation from SpotGamma:</p><blockquote>When implied volatility is very high, its very sensitive to market moves and also signaling that markets are expecting more large moves ahead. As soon as markets would pause or catch a support level, that implied volatility would quickly reverse lower. <b>We often think of this analogy that if a shark stops swimming, it sinks ( partially true!). If the market stops dropping then Implied volatility sinks.</b></blockquote><p>With this, as we often talk about, lower implied volatility (ie lower VIX) signals market makers have to buy back short hedges which fuels rallies. SG's conclusion: this current level of lower implied volatility now gives the market more downside firepower.&nbsp; Starting with a lower implied volatility “slows down” that responsive “snap-back” buying mechanism.&nbsp; Additionally, gamma is higher when IV is lower so gamma flips may have more juice.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$544 Billion In Options Expire Today: Here's What Will Move</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$544 Billion In Options Expire Today: Here's What Will Move\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 22:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/544-billion-options-expire-today-heres-what-will-move?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175692875","content_text":"While it's not quad (or even triple) witching day, today's a whole lot of weekly options will expire, may of which will be worthless, and others will be providing a supporting \"pin\" to underlying prices. It's why, even though we are enjoying a beautiful spring week, Goldman notes that single stock options trading activity is elevated relative to historical levels. To wit, daily options volumes are up 70% in April, up from YTD lows of $2.4bn on 30-Mar.In total, across single stocks, $544BN of options are set to expiry today, including $305BN calls.As such, today’s expiry could be important for stocks with large open interest in at-the-money(ATM) options, as market makers delta-hedging their unusually large options portfolios will be active. This flow is likely to dampen volatility in some names while exacerbating stock price moves in others.How to trade this?As Goldman's Vishal Vivek writes, at major expirations, options traders track situations wherea large amount of open interest is set to expire.In situations where there is a significant amount of expiring open interest in at-the-money strikes (strike prices at or very near the current stockprice), delta-hedging activity can impact the underlying stock’s trading that day. If market makers or other options traders who delta-hedge their positions are net long ATM options, expiration-related flow could have the effect of dampening stock price movements, causing the stock price to settle near the strike with large open interest. This situation is often referred to as a “pin” and can be an ideal situation fora large investor trying to enter/exit a stock position. Alternatively, if delta-hedgers are net short ATM options (have a “negative gamma” position), their hedging activity could exacerbate stock price moves.What that means it expiration-related trades may cause trading activity to aggressively pick up for stocks with a significant amount of ATM open interest.So to help traders looking to hop on for daytrading opportunities, here is a table identifying possible focus stocks with large ATM open interest expiring today, which is compared to the average daily volume of the underlying stocks. As Goldman puts it, \"expiration-related activity is likely to have more of an impact if the open interest represents a significant percentage of the stock’s volume.\"Finally, for what it's worth, this morning our friends at SpotGamma write that this has been a rather strange OPEX cycle, \"with a consistent almost mechanical bid pushing markets higher. We’ve not seen the Call Wall “breached” this many times before, but there are other aberrations that we’ve mentioned in previous notes – like net put sales. We’ve got some theories on this we are posting in a longer form piece.\"According to SG, because implied volatility has now compressed (ie VIX at new lows) there is now more potential for “long term” volatility. Recall how as of late any sharp, violent drop in markets was bought so quickly (see chart below).These bursts lower coincided with record VIX spikes, but a reflective snap-back bid would bring a market recovery of equal force as the VIX  (i.e. implied volatility) reversed.And one other curious observation from SpotGamma:When implied volatility is very high, its very sensitive to market moves and also signaling that markets are expecting more large moves ahead. As soon as markets would pause or catch a support level, that implied volatility would quickly reverse lower. We often think of this analogy that if a shark stops swimming, it sinks ( partially true!). If the market stops dropping then Implied volatility sinks.With this, as we often talk about, lower implied volatility (ie lower VIX) signals market makers have to buy back short hedges which fuels rallies. SG's conclusion: this current level of lower implied volatility now gives the market more downside firepower.  Starting with a lower implied volatility “slows down” that responsive “snap-back” buying mechanism.  Additionally, gamma is higher when IV is lower so gamma flips may have more juice.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":342023876,"gmtCreate":1618132449795,"gmtModify":1704706884610,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342023876","repostId":"1104081344","repostType":4,"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370872712,"gmtCreate":1618577924936,"gmtModify":1704712977819,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/370872712","repostId":"2127664834","repostType":4,"repost":{"id":"2127664834","pubTimestamp":1618573860,"share":"https://ttm.financial/m/news/2127664834?lang=&edition=fundamental","pubTime":"2021-04-16 19:51","market":"us","language":"en","title":"4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2127664834","media":"Motley Fool","summary":"And they all have one key thing in common.","content":"<p>Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of <b>Tesla</b> (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b>. But Wood also likes several healthcare stocks. In this <i>Motley Fool Live</i> video <b>recorded on April 7</b>, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.</p>\n<p><b>Keith Speights:</b> All right. Let's switch to a fun story, Brian. Now, you and I, we cover healthcare. We don't get to talk about stocks like Tesla very often, we just don't. We're going to talk about Tesla, kind of.</p>\n<p>Cathie Wood, famous investor, very well-known investor, highly followed investor. Her ARK Invest came out not long ago with a 2025 price target for Tesla that caused all kinds of controversy. It's way higher than Tesla's current price. They took a beating for predicting that Tesla's shares were going to really just skyrocket over the next few years.</p>\n<p>But Cathie Wood also likes quite a few healthcare stocks. I'm curious, Brian. Are there any of Cathie Wood's favorite healthcare stocks that you think could deliver bigger gains than Tesla will over the next five years?</p>\n<p><b>Brian Orelli:</b> Yeah. The only <a href=\"https://laohu8.com/S/AONE\">one</a> in the top holdings that I saw that I own is <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX). It's big and in cystic fibrosis. Growth has been slowing down as it will treat more patients with its different medications. It's up to maybe three to four medications depending on how you count the combinations.</p>\n<p>It needs to find its next growth driver. There's plenty of pipeline candidates both internally developed, as well as licensed products. Among the licensed products, <b>CRISPR Therapeutics</b> (NASDAQ:CRSP) has a deal with the company. They have a treatment for beta-thalassemia and sickle cell that's already in clinical trials and has shown early efficacy, and then they have some earlier programs in Duchenne's muscular dystrophy, a disease called DM1, and cystic fibrosis.</p>\n<p>On the rest of her list, I really like <b>Regeneron</b> (NASDAQ:REGN). It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> that I've always wished I owned, but it always seemed a little expensive. But that's the way good companies go sometimes and so sometimes, you just have to bite the bullet and buy it and I never did.</p>\n<p>If you're going to buy a large biotech company, you want to go for one with a lot of shots on goal and Regeneron has maybe almost the most shots on goal. It's really done well. I can't even think of Regeneron drug that has actually failed. I think maybe that's one of the reasons why it's doing well, even though it's had a really high price. Valuation is just because it's had so few failures, it's done really well at developing antibodies and being successful at that.</p>\n<p><b>Anything on the list that you saw?</b></p>\n<p><b>Speights:</b> Yeah. First, I would agree with you on both Vertex and Regeneron. The tickers there by the way are VRTX for Vertex and REGN for Regeneron. Yeah. When you're looking at big biotechs, those two are my favorites.</p>\n<p>Like you Brian, I own Vertex. I don't own Regeneron, but also like you, I wish I had bought it several years ago. Those are great picks that I do think both of those depending on how their pipeline candidates play out over the next few years, both of those stocks could potentially beat Tesla.</p>\n<p>I also like and own <b>Teladoc Health</b> (NYSE:TDOC). Ticker there is TDOC. That's another Cathie Wood favorite that she is very bullish on. I think Teladoc Health has been beaten down quite a bit over the last couple of months, but I think it's a stock that could very easily outperform Tesla over the next five years as virtual care really gains momentum.</p>\n<p>I will throw in a much riskier stock that I don't own, but just I've started doing a little research into. It's a stock called <b>Twist Bioscience</b> (NASDAQ:TWST). The ticker there is TWST. What Twist does is it makes synthetic DNA. The company offers next-generation sequencing products. It develops antibodies for biopharma companies, it's working on storing data and DNA.</p>\n<p>The market cap right now is only around $6 billion. They generated revenue of $90 million last year. It's priced at a premium, but investors are expecting great things from Twist Bioscience. Again, it's one of Cathie Wood's favorite biotech stocks and it's one that, like I said, is really risky, but it could pay off over the long run. It's one that I'm keeping my eye on.</p>\n<p><b>Orelli:</b> Twist just came on to my watchlist like in the last week.</p>\n<p><b>Speights:</b> Yeah.</p>\n<p><b>Orelli:</b> Because it was spurred on by this podcast. Luke Timmerman does a podcast called <i>The Long Run</i>, and the CEO, Emily Leproust was on the podcast. I'll put that link to that podcast in the chat. If anybody wants to get more information on Twist and what they're doing, I think that was a really interesting podcast.</p>\n<p><b>Speights:</b> Maybe sometime in the not-too-distant future, Brian, you and I can go a little deeper, dive into Twist Bioscience just to give our viewers more information about this biotech that's on both of our watchlists right now.</p>\n<p><b>Orelli:</b> Yeah, that sounds good.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 19:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, ARK Innovation ETF. But Wood...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/04/16/4-cathie-wood-stocks-that-could-deliver-bigger-gai/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2127664834","content_text":"Everyone knows that ARK Invest CEO Cathie Wood is a huge fan of Tesla (NASDAQ:TSLA). Elon Musk's company ranks as the top position in Wood's flagship exchange-traded fund, ARK Innovation ETF. But Wood also likes several healthcare stocks. In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli identify four healthcare stocks that are among Wood's top holdings that just might deliver bigger gains than Tesla.\nKeith Speights: All right. Let's switch to a fun story, Brian. Now, you and I, we cover healthcare. We don't get to talk about stocks like Tesla very often, we just don't. We're going to talk about Tesla, kind of.\nCathie Wood, famous investor, very well-known investor, highly followed investor. Her ARK Invest came out not long ago with a 2025 price target for Tesla that caused all kinds of controversy. It's way higher than Tesla's current price. They took a beating for predicting that Tesla's shares were going to really just skyrocket over the next few years.\nBut Cathie Wood also likes quite a few healthcare stocks. I'm curious, Brian. Are there any of Cathie Wood's favorite healthcare stocks that you think could deliver bigger gains than Tesla will over the next five years?\nBrian Orelli: Yeah. The only one in the top holdings that I saw that I own is Vertex Pharmaceuticals (NASDAQ:VRTX). It's big and in cystic fibrosis. Growth has been slowing down as it will treat more patients with its different medications. It's up to maybe three to four medications depending on how you count the combinations.\nIt needs to find its next growth driver. There's plenty of pipeline candidates both internally developed, as well as licensed products. Among the licensed products, CRISPR Therapeutics (NASDAQ:CRSP) has a deal with the company. They have a treatment for beta-thalassemia and sickle cell that's already in clinical trials and has shown early efficacy, and then they have some earlier programs in Duchenne's muscular dystrophy, a disease called DM1, and cystic fibrosis.\nOn the rest of her list, I really like Regeneron (NASDAQ:REGN). It's one that I've always wished I owned, but it always seemed a little expensive. But that's the way good companies go sometimes and so sometimes, you just have to bite the bullet and buy it and I never did.\nIf you're going to buy a large biotech company, you want to go for one with a lot of shots on goal and Regeneron has maybe almost the most shots on goal. It's really done well. I can't even think of Regeneron drug that has actually failed. I think maybe that's one of the reasons why it's doing well, even though it's had a really high price. Valuation is just because it's had so few failures, it's done really well at developing antibodies and being successful at that.\nAnything on the list that you saw?\nSpeights: Yeah. First, I would agree with you on both Vertex and Regeneron. The tickers there by the way are VRTX for Vertex and REGN for Regeneron. Yeah. When you're looking at big biotechs, those two are my favorites.\nLike you Brian, I own Vertex. I don't own Regeneron, but also like you, I wish I had bought it several years ago. Those are great picks that I do think both of those depending on how their pipeline candidates play out over the next few years, both of those stocks could potentially beat Tesla.\nI also like and own Teladoc Health (NYSE:TDOC). Ticker there is TDOC. That's another Cathie Wood favorite that she is very bullish on. I think Teladoc Health has been beaten down quite a bit over the last couple of months, but I think it's a stock that could very easily outperform Tesla over the next five years as virtual care really gains momentum.\nI will throw in a much riskier stock that I don't own, but just I've started doing a little research into. It's a stock called Twist Bioscience (NASDAQ:TWST). The ticker there is TWST. What Twist does is it makes synthetic DNA. The company offers next-generation sequencing products. It develops antibodies for biopharma companies, it's working on storing data and DNA.\nThe market cap right now is only around $6 billion. They generated revenue of $90 million last year. It's priced at a premium, but investors are expecting great things from Twist Bioscience. Again, it's one of Cathie Wood's favorite biotech stocks and it's one that, like I said, is really risky, but it could pay off over the long run. It's one that I'm keeping my eye on.\nOrelli: Twist just came on to my watchlist like in the last week.\nSpeights: Yeah.\nOrelli: Because it was spurred on by this podcast. Luke Timmerman does a podcast called The Long Run, and the CEO, Emily Leproust was on the podcast. I'll put that link to that podcast in the chat. If anybody wants to get more information on Twist and what they're doing, I think that was a really interesting podcast.\nSpeights: Maybe sometime in the not-too-distant future, Brian, you and I can go a little deeper, dive into Twist Bioscience just to give our viewers more information about this biotech that's on both of our watchlists right now.\nOrelli: Yeah, that sounds good.","news_type":1},"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347016604,"gmtCreate":1618449105508,"gmtModify":1704710968776,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"What’s&nbsp;a good price&nbsp;to buy again?","listText":"What’s&nbsp;a good price&nbsp;to buy again?","text":"What’s a good price to buy again?","images":[{"img":"https://static.tigerbbs.com/6b80b90c166da6181d19ef5090442fc7","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/347016604","isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":344885164,"gmtCreate":1618397176258,"gmtModify":1704710162727,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"My pick of the REITS in Sg&nbsp;","listText":"My pick of the REITS in Sg&nbsp;","text":"My pick of the REITS in Sg","images":[{"img":"https://static.tigerbbs.com/a3cf30b8a1bd1d8884e810aea28e9223","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344885164","isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":342612428,"gmtCreate":1618209305264,"gmtModify":1704707532364,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342612428","repostId":"342890542","repostType":1,"repost":{"id":342890542,"gmtCreate":1618195126286,"gmtModify":1704707355770,"author":{"id":"3553398469738690","authorId":"3553398469738690","name":"Sufiknight","avatar":"https://static.tigerbbs.com/15e40690d5aba75f7d0bfb1c31e35254","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3553398469738690","idStr":"3553398469738690"},"themes":[],"htmlText":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks&nbsp;poised to retest $5.50 in the near term.&nbsp;","listText":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks&nbsp;poised to retest $5.50 in the near term.&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$BB is tightening. A breakdown seems imminent. Technically, looks poised to retest $5.50 in the near term.","images":[{"img":"https://static.tigerbbs.com/4eb4bdaa097a9d13f0bafabb978b7745","width":"720","height":"1549"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/342890542","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346898819,"gmtCreate":1618019140131,"gmtModify":1704706004418,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"Apple at $133 still can buy?","listText":"Apple at $133 still can buy?","text":"Apple at $133 still can buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346898819","isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346893343,"gmtCreate":1618019067682,"gmtModify":1704706000862,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"At this price still can buy?","listText":"At this price still can buy?","text":"At this price still can buy?","images":[{"img":"https://static.tigerbbs.com/e2ded09140977194799e5916bdaf20a5","width":"750","height":"2602"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346893343","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":348633124,"gmtCreate":1617924878168,"gmtModify":1704704794599,"author":{"id":"3578184198505037","authorId":"3578184198505037","name":"faeriewoods","avatar":"https://static.tigerbbs.com/04104cc9ab397d96e0eeee3c1023d9ad","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578184198505037","idStr":"3578184198505037"},"themes":[],"htmlText":"My first REIT","listText":"My first REIT","text":"My first REIT","images":[{"img":"https://static.tigerbbs.com/15ef6dbba2ea7c9c67f5d98d332c8bb4","width":"750","height":"1618"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348633124","isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}